The store will not work correctly when cookies are disabled.
1-(8-Methoxy-4-o-tolylamino-quinolin-3-yl)-butan-1-ol (0.5H2O)
ID: ALA116786
PubChem CID: 10427130
Max Phase: Preclinical
Molecular Formula: C21H24N2O2
Molecular Weight: 336.44
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CCCC(O)c1cnc2c(OC)cccc2c1Nc1ccccc1C
Standard InChI: InChI=1S/C21H24N2O2/c1-4-8-18(24)16-13-22-21-15(10-7-12-19(21)25-3)20(16)23-17-11-6-5-9-14(17)2/h5-7,9-13,18,24H,4,8H2,1-3H3,(H,22,23)
Standard InChI Key: QAGWRXTZANBLKN-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
3.2792 -5.9417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9917 -6.3625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5667 -6.3542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2875 -5.1167 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.2792 -7.5917 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.5667 -7.1792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9917 -7.1875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5750 -4.7042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8542 -7.5917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7125 -5.9542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5792 -3.8792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8542 -5.9417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8625 -8.4167 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.7167 -5.1292 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.1500 -6.3542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8625 -5.1167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1500 -7.1792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2917 -3.4667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8667 -3.4667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4250 -6.3667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1417 -8.8292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1417 -5.9625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1500 -4.7042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8542 -6.3792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1500 -3.8792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 1 2 0
4 1 1 0
5 6 2 0
6 3 1 0
7 2 2 0
8 4 1 0
9 6 1 0
10 2 1 0
11 8 2 0
12 3 1 0
13 9 1 0
14 10 1 0
15 12 2 0
16 8 1 0
17 15 1 0
18 11 1 0
19 11 1 0
20 10 1 0
21 13 1 0
22 20 1 0
23 16 2 0
24 22 1 0
25 23 1 0
5 7 1 0
17 9 2 0
25 19 2 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 336.44 | Molecular Weight (Monoisotopic): 336.1838 | AlogP: 5.13 | #Rotatable Bonds: 6 |
Polar Surface Area: 54.38 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 2 |
#RO5 Violations: 1 | HBA (Lipinski): 4 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: ┄ | CX Basic pKa: 5.20 | CX LogP: 4.54 | CX LogD: 4.54 |
Aromatic Rings: 3 | Heavy Atoms: 25 | QED Weighted: 0.66 | Np Likeness Score: -0.62 |
References
1. Ife RJ, Brown TH, Keeling DJ, Leach CA, Meeson ML, Parsons ME, Reavill DR, Theobald CJ, Wiggall KJ.. (1992) Reversible inhibitors of the gastric (H+/K+)-ATPase. 3. 3-substituted-4-(phenylamino)quinolines., 35 (18): [PMID:1326634] [10.1021/jm00096a018] |